Liposomal products in general can be defined as specialized formulations of nutraceuticals encapsulated in liposomes.
A liposomal CoQ10 is a Coenzyme Q10 that uses a revolutionary Liposomal delivery system providing VERY TINY nano sized …Read More
Tween 80 belongs to a class of food additives also known as Polysorbates. Span 80 or Sorbitan monooleate is a Sorbitan Ester widely used in food products and oral pharmaceuticals.
Both are considered a non-ionic surface active agent**. And, are listed in the USP/NF, BP, EP, etc., as an approved pharmaceutical excipient for …Read More
Landmark study proves mitochondrial uptake of supplemental Coenzyme Q10 (Q-Gel®) in the heart and brain.
A study published in the peer reviewed Journal “Free Radical Biology and Medicine”, Vol. 33 No. 5, pp 627-638, 2002, titled, &qu …Read More
What is an Orphan Drug Designation?
An Orphan Drug Designation is a special status granted by the FDA. The intent of orphan drug designation is to encourage the research, development and approval of products that treat rare diseases. A rare disease is a disease afflicting less than 200,00 …Read More
What is CoQ10 and Why is it Considered a Miracle Nutrient?
Coenzyme Q10, or CoQ10 for short, is a vitamin like nutrient that plays the role of both an antioxidant and a cellular energizer. It was first discovered in 1958 and given the scientific name Ub …Read More
The following information is from a U.S. Government web site (the National Cancer Institute at the National Center for Complementary and Alternative Medicine
What is the history of the discovery and use of coenzyme Q10 as a complementary or alternative treatment for cancer?
Coenzyme Q10 …Read More
The effects of oral treatment with coenzyme Q10 (120 mg per day) were compared for 28 days in a randomized, double-blind placebo-controlled trial of coenzyme Q10 in patients with acute myocardial infarction.
The trial consisted of a total of 144 patients with acute myocardial infarction (AMI). 73 of the 144 patients were p …Read More
The global coenzyme Q10 (CoQ10) market is expected to reach USD 1.36 billion by 2024, according to a new report by Grand View Research, Inc. Increasing use in cosmetic formulations is a key driving factor for industry growth.
Asia Pacific is poised to be the fastest growing regional market …Read More
Systemic hypertension, (high blood pressure), affects more than 60 million adults in the United States. Worldwide, it is one of the most common risk factors for cardiovascular morbidity and mortality.
A randomized, double-blind, placebo-controlled clinical trial of Coenzyme Q10 in Isolated Systolic Hypertension was recently …Read More
In the November 2003 issue of Good Housekeeping, (page 83), leading heart surgeon Mehmet Oz, (Professor of Surgery at Columbia University College of Physicians & Surgeons and Attending Surgeon at Columbia Presbyterian Division of Cardiothoracic Surgery …Read More